| CL |
Report |
Organic sales growth |
MISS |
pred ~2.2% vs. cons 2.44% |
MEDIUM |
| CL |
Report |
Base Business diluted EPS |
IN-LINE |
pred ~$0.950 vs. cons $0.948 |
MEDIUM |
| CL |
Report |
North America O,P&H organic sales growth |
MISS |
pred ~-2.0% vs. cons -1.14% |
MEDIUM |
| CL |
Guide |
FY2026 organic sales growth |
LOWER |
guide 1%-4% vs. cons 2.90%; midpoint 2.5% |
MEDIUM |
| CL |
Guide |
FY2026 Base Business EPS growth |
UNCHANGED |
guide low to mid-single-digit vs. numerical consensus comparison UNVERIFIED |
LOW |
| CL |
Guide |
FY2026 gross margin |
UNCHANGED |
guide down year-over-year vs. numerical comparison UNVERIFIED |
LOW |
| CL |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| CL |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — organic and North America weakness should pressure out-period expectations |
LOW |